3-Bromopyruvic acid

  Cat. No.:  DC22490   Featured
Chemical Structure
1113-59-3
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
A glycolytic inhibitor that inhibits hexokinase II activity, suppresses ATP production, and induces endoplasmic reticulum (ER) stress.
Cas No.: 1113-59-3
Chemical Name: 3-Bromopyruvic acid
Synonyms: 3-Bromopyruvic acid;3-BROMO-2-OXOPROPANOIC ACID;3-BROMO-2-OXOPROPIONIC ACID;BROMOPYRUVIC ACID;3-bromo-2-oxo-propanoicaci;3-bromopyruvate;beta-bromopyruvicacid;bromopyruvate;bromo-pyruvicaci;3-BROMOPYRUVIC ACID CRYSTALLINE;Bromopyruvicacidhydrate;3-BROMO-2-OXOPROPANOICACID(3-BROMOPYRUVICACID);2-Oxo-3-bromopropanoic acid;2-Oxo-3-bromopropionic acid;3-BROMO-2-OXO-PROPIONIC ACID;3-BromopYHuvic acid;3-BROMOPYRUVIC ACID HYDRATE;3-BROMOPYRUVICACID(3-BROMOPYRUVATE);Hexokinase II Inhibitor II, 3-BP;PROPANOIC ACID,3-BROMO-2-OXO-;3-Bromo-2-oxopropionic Acid;NS00023565;NS00023565;EN300-67360;EN300-67360;CHEBI:95046;CHEBI:95046;Bromopyruvic acid; 3-bromo-2-oxopropanoic acid;Bromopyruvic acid; 3-bromo-2-oxopropanoic acid;Bromopyruvic acid, >=97.0% (T);Bromopyruvic acid, >=97.0% (T);3-bromo-2-oxopropanoic acid;3-Bromopyruvic acid;3-bromo-2-oxopropanoic acid;3-Bromopyruvic acid;bromopyruvic acid;bromopyruvic acid;3-BP;3-BP;.beta.-Bromopyruvic acid;NSC-62343;.beta.-Bromopyruvic acid;NSC-62343;EINECS 214-206-5;NSC 11731;EINECS 214-206-5;NSC782120;NSC 11731;FT-0623262;NSC782120;BRD-K92980438-001-01-7;FT-0623262;BRD-K92980438-001-01-7;Z1079181768;Z1079181768;Bromopyruvicacid;Bromopyruvicacid;Hexokinase II Inhibitor II, 3-BP - CAS 1113-59-3;Hexokinase II Inhibitor II, 3-BP - CAS 1113-59-3;3-Bromo-2-oxopropionic acid;3-Bromo-2-oxopropionic acid;NSC-11731;NSC-11731;Propanoic acid, 3-bromo-2-oxo-;3-bromo-2-oxo-propionic acid;Propanoic acid, 3-bromo-2-oxo-;J-650255;3-bromo-2-oxo-propionic acid;J-650255;1113-59-3;1113-59-3;BPV;BPV;CS-5517;NSC11731;CS-5517;Q3608257;NSC11731;NSC62343;Q3608257;3-BrPA;NSC62343;MFCD00002587;3-BrPA;Pyruvic acid, bromo-;HY-19992;MFCD00002587;3-Bromopyruvic acid hydrate,98;Pyruvic acid, bromo-;HY-19992;B1153;SCHEMBL8126;3-Bromopyruvic acid hydrate,98;bromo-2-oxopropanoic acid;B1153;beta-Bromopyruvic acid;SCHEMBL8126;s5426;bromo-2-oxopropanoic acid;AM84337;beta-Bromopyruvic acid;AS-16146;s5426;AKOS015892643;AM84337;63JMV04GRK;AS-16146;NSC 62343;AKOS015892643;63JMV04GRK;3-bromopyruvic acid;HMS3866H13;NSC 62343;CCG-266336;3-bromopyruvic acid;Hexokinase II Inhibitor II;3-BP;HMS3866H13;J-511892;CCG-266336;UNII-63JMV04GRK;Hexokinase II Inhibitor II;3-BP;BRN 1746786;J-511892;3-Bromo-2-oxopropanoic acid #;UNII-63JMV04GRK;CHEBI:131461;BRN 1746786;3-bromo-2-oxopropanoic acid;3-Bromo-2-oxopropanoic acid #;3-bromo-2-keto-propionic acid;CHEBI:131461;NSC-782120;3-bromo-2-oxopropanoic acid;HMS3741K19;3-bromo-2-keto-propionic acid;3-bromopyruvicacid;NSC-782120;DTXSID7040940;HMS3741K19;CHEMBL177837;3-bromopyruvicacid;NCIOpen2_000241;DTXSID7040940;CHEMBL177837;NCIOpen2_000241
SMILES: O=C(O)C(CBr)=O
Formula: C3H3BrO3
M.Wt: 166.96
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: A glycolytic inhibitor that inhibits hexokinase II activity, suppresses ATP production, and induces endoplasmic reticulum (ER) stress; potentiates acetate-induced apoptosis and anti-proliferative effect in CRC cells; abrogates MUC1-mediated radiation resistance both in vitro and in vivo pancreatic cancer models, by reducing glucose flux into nucleotide biosynthetic pathways and enhancing DNA damage.
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
Cat. No. Product name Field of application
DC31074 Isopropyl myristate Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC74557 PREX-in1 PREX-in1 is a specific small-molecule inhibitor of P-Rex1 and P-Rex2 Rac-GEF activity with IC50 of 4.5 uM (P-Rex1 DHPH Rac-GEF activity) in liposome-based GEF assay, inhibits P-Rex1 and P-Rex2 through their catalytic DH domain.
DC74555 GYS32661 GYS32661 (GYS 32661) is a potent Rac inhibitor capable of inhibiting both Rac1 and Rac1b, inhibited activated Rac1 with IC50 of 1.18 uM in in vitro pull-down assays.
DC74539 L557-0155 L557-0155 is a small molecule inhibitor of VSIG-8, prevents VSIG-8 binding to VISTA, promotes cytokine production and cell proliferation in PBMCs and suppresses melanoma growth.
DC74528 K284 K284 is a selective small molecule inhibitor of chitinase 3 like1 (CHI3L1) with strong binding affinity (Kd=-9.7 kcal·mol-1), inhibits lung metastasis by blocking IL-13Rα2-mediated JNK-AP-1 signals.
DC74225 YB-537 YB-537 (YB537) is a potent, highly specific quinone reductase 2 (QR2) inhibitor with IC50 of 3 nM, shows no activity against QR1 (IC50>10 uM).
DC74223 X-Neu5Ac X-Neu5Ac (sodium) is a substrate for chromogenic assay of neuraminidase activity in bacterial expression systems; with a Km of 0.89 mM for neuraminidase.
DC74218 UT-59 UT-59 is a specific inhibitor of cholesterol-sensing membrane protein Scap, binds to Scap's cholesterol-binding site, blocks SREBP activation and inhibits lipid synthesis.
DC74205 Tryptolinamide Tryptolinamide (TLAM) is a small-molecule compound that activates mitochondrial respiration in cybrids generated from patient-derived mitochondria and fibroblasts from patient-derived iPSCs, inhibits phosphofructokinase-1 (PFK1) with an ATP-uncompetitive
DC74203 TR-107 TR-107 (TR107) is a highly potent, selective and orally bioavailable small-molecule activator of the mitochondrial protease ClpP with EC50 of 140 nM, binds to purified ClpP with Kd value of 180 nM in surface plasmon resonance (SPR) measurement.
X